System analysis and evaluation of pharmacoeconomic literatures of cancer published in China

Liping FAN,Yuanyuan JIAO,Zihan GUO,Yanhua ZHANG

DOI: https://doi.org/10.19577/j.cnki.issn10074406.2016.03.012

2016-01-01

Abstract:AIM To analyze and evaluate the quality of pharmacoeconomic literatures of cancer published in China,and understand the status of pharmacoeconomic evaluation studies.METHODS Pharmacoeconomic evaluation literatures published on domestic professional journals from 2010 to 2014 were researched.According to pharmacoeconomic evaluation criteria,the quality of included studies was evaluated.RESULTS There were 53 literatures included,the researchers were mainly pharmacists;most of researchers had no funding;the journals were widely dispersed;chemotherapy regimens were commonly used;retrospective study and cost-effectiveness analysis were commonly used;most of literatures took direct medical costs as cost indicators and carried out sensitivity analysis on the drug prices.CONCLUSION The contents of literatures conform to the clinical demand,but lack enough attention,and the quality of which overall is low;especially the perspective of most studies is not clear;the scope of the cost is too narrow;the discount issue is easily ignored;design of study should be improved;and sensitivity analysis is single.